Douglas G. Muse is consultant—Compendial Affairs, Eli Lilly & Co.
Understanding Concomitant Components in Pharmaceutical Excipients
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
Additives and Processing Aids in Pharmaceutical Excipients
This article seeks to encourage continued dialogue among stakeholders to achieve consensus regarding excipient additives and processing aids.